Private Tender Offers: When Founders Lose QSBS

Private tender offers are the pre-IPO liquidity mechanism for late-stage startups. A growth equity investor or sovereign wealth fund offers to purchase a portion of founder and employee equity at a negotiated price, providing real cash for paper wealth without requiring an IPO. For founders sitting on $20M-$100M of illiquid equity in companies five or seven years from realistic IPO, the tender offer is often the difference between staying motivated and stepping away.

For QSBS planning, the tender offer is a trap. IRC section 1202(c)(3) disqualifies QSBS treatment when the corporation engages in "significant" stock redemptions during specified windows around the QSBS issuance. The rules were designed to prevent a specific abuse — issuing QSBS while simultaneously redeeming pre-QSBS shares to create economically equivalent but tax-favored positions — but they apply mechanically to legitimate tender offers as well. A poorly-structured tender offer can disqualify $20M or more of a founder's otherwise-eligible QSBS, generating a $4.76M federal tax bill on stock that would have been federally tax-free.

The two redemption rules under section 1202(c)(3)

Section 1202(c)(3) actually contains two independent disqualification rules. Each must be analyzed separately, and either one can disqualify the QSBS.

Rule 1 — Related-person redemptions: section 1202(c)(3)(A)

IRC section 1202(c)(3)(A) provides that stock acquired by the taxpayer is not QSBS if, at any time during the 4-year period beginning 2 years before the date of issuance, the corporation redeemed stock from the taxpayer or a related person (defined under IRC sections 267(b) or 707(b)) — unless the redemption was de minimis under Treas. Reg. section 1.1202-2(a)(2).

The de minimis safe harbor under Treas. Reg. section 1.1202-2(a)(2): redemptions from the taxpayer or a related person are disregarded if they do not exceed the greater of $10,000 or 2% of the value of the taxpayer's stock in the corporation at the relevant time. The safe harbor is highly restrictive — for any founder with stock worth more than $500,000, the 2% threshold caps redemptions at $10,000.

The related-person rule applies on a per-taxpayer basis. If the corporation redeems stock from Founder A within 2 years of issuing QSBS to Founder A, Founder A's new QSBS is disqualified — but Founder B's QSBS (from a separate issuance to Founder B) may not be affected, unless Founder B is a related person under sections 267(b) or 707(b).

Rule 2 — General redemption rule: section 1202(c)(3)(B)

IRC section 1202(c)(3)(B) provides that stock acquired by the taxpayer is not QSBS if, during the 2-year period beginning 1 year before the date of issuance and ending 1 year after, the corporation redeemed more than 5% of the aggregate value of all of its stock (measured as of the date of issuance). The 5% threshold is measured against aggregate company value, not against the taxpayer's individual stock.

Treas. Reg. section 1.1202-2(b)(1) clarifies that the "significant redemption" threshold is 5% — at or below 5%, the general rule does not apply; above 5%, the rule triggers disqualification of all QSBS issued in the 2-year window.

The 2-year window in the general rule is asymmetric — 1 year before and 1 year after issuance — and uses calendar years from the issuance date. The aggregate value measurement uses the company's fair market value at the date of issuance, often determined by reference to recent financing rounds or third-party valuations.

The trap: legitimate tender offers can trigger both rules

A tender offer is, in form, a redemption of stock if the corporation is the buyer — and even when structured with a third-party investor, it is functionally similar to a redemption from the founder's perspective. Section 1202(c)(3) does not distinguish between abusive redemptions and legitimate liquidity events. Mechanical application of the rules can disqualify QSBS in tender scenarios that have no abusive purpose.

Consider a pre-IPO company that conducts a $40M tender offer in early 2027, alongside a Series D financing also in 2027. Founders and employees collectively tender stock representing 4% of company value (well below the 5% general-rule threshold). For each founder participating in the tender, the 2% related-person threshold is exceeded — meaning the founder's new QSBS issuances (from option exercises, employee grants, or additional founder grants in the 4-year window straddling the tender) may be disqualified under the related-person rule.

The result: QSBS issued in 2025-2029 to founders who tendered in 2027 is potentially disqualified, even though the tender size (4% of company value) was well below the general-rule threshold.

Worked example: a $5M tender that disqualifies $20M of QSBS

Consider a Bay Area founder, Marcus, who owns stock in his Series C-stage SaaS company. The company has a $250M post-money valuation. Marcus has stock worth approximately $25M (10% of fully-diluted equity). He has three tranches of QSBS:

• Tranche 1: Founder stock issued at incorporation in 2021, worth ~$15M, basis $100K
• Tranche 2: Additional founder grant in 2024, worth ~$6M, basis $50K (with 83(b) election)
• Tranche 3: Option exercise stock acquired in early 2026, worth ~$4M, basis $200K

In late 2026, the company offers a tender for liquidity. Marcus tenders $5M of stock (drawn proportionally from his tranches). The company purchases the stock — making this a corporate redemption rather than a third-party purchase.

Section 1202(c)(3)(B) analysis — the general rule

• Total company value: $250M
• Tender size: $5M (Marcus only) plus tenders from other founders and employees: assume $12M aggregate company-wide
• $12M / $250M = 4.8% of aggregate company value — below the 5% threshold
• General rule under section 1202(c)(3)(B): NOT triggered

Section 1202(c)(3)(A) analysis — the related-person rule

• Marcus's stock value before tender: $25M
• Marcus's tender: $5M — 20% of his stock value
• 2% de minimis threshold: $500K
• Tender exceeds the 2% threshold: related-person rule TRIGGERED
• All QSBS issued to Marcus in the 4-year window straddling the tender (2024-2028) is disqualified

Affected QSBS: Tranche 2 (issued 2024, within 2 years before tender) and Tranche 3 (issued early 2026, within 2 years before tender). Combined value of disqualified QSBS: $10M ($6M + $4M).

Tranche 1 (issued 2021, outside the 2-year-before window) is NOT affected by the tender — that tranche retains its QSBS character.

Tax impact at eventual exit

Assume Marcus eventually sells the entire company in 2030 at a $400M enterprise value. His pro-rata share (post-tender adjusted to roughly 8.4%): $33.6M. Allocate proceeds across his three tranches and account for the tender already received ($5M).

• Tranche 1 (still QSBS-eligible): Gain ~$23M; section 1202 exclusion: $10M; taxable gain: $13M; federal tax 23.8%: $3.09M
• Tranches 2 and 3 (disqualified by the tender): Combined gain ~$10M; no section 1202 exclusion; full 23.8% tax: $2.38M
• Counterfactual: had the tender been structured to clear safe harbors, Tranches 2 and 3 would be QSBS-eligible — each with its own $10M cap, combining to exclude up to $10M each. Marcus's federal tax bill would have been $1.19M lower (excluding an additional $5M of gain at 23.8%).

The cost of the disqualification

The tender offer that provided Marcus with $5M of liquidity also cost him approximately $1.19M in federal tax at eventual exit — a 23.8% effective "cost" on the tender liquidity itself. For a founder who genuinely needed the $5M cash, this may have been an acceptable price. For a founder who could have structured the tender differently or waited, the disqualification was avoidable.

How to structure a tender offer to preserve QSBS

Several structuring choices can preserve QSBS through a tender offer:

1. Use a genuine third-party purchaser

If the buyer is a truly independent third party (a growth equity fund, a hedge fund, a sovereign wealth fund) that approaches the founders independently, conducts its own due diligence, and pays its own money, the purchase is generally not a redemption by the corporation. Section 1202(c)(3) does not apply because the corporation is not redeeming its own stock — the third party is buying stock from existing shareholders.

The structural requirements for "genuine third party" status: the corporation does not arrange or financially support the purchase, the third party is not a related party of the corporation under IRC section 267(b), and the purchase is at arm's length pricing. Corporate-facilitated tenders (where the corporation arranges the buyer or guarantees the purchase) may be recharacterized as constructive corporate redemptions even if formally structured as third-party purchases.

2. Time the tender outside the 2-year QSBS-issuance windows

For corporate redemption-style tenders, timing the tender outside the 2-year window before any anticipated QSBS issuance (and outside the 2-year window after the last QSBS issuance) avoids the related-person rule entirely. For a company that issued its last QSBS in 2024 and plans no further issuances until 2028, a tender in 2026 falls outside both windows — and the related-person rule does not apply.

This is difficult for pre-IPO companies that continuously issue QSBS through option exercises and employee stock grants. The 2-year-after window applies to every issuance, so virtually any tender during active hiring/granting periods will be within someone's window.

3. Stay under the 5% general-rule threshold

For tender offers structured as corporate redemptions, ensuring the aggregate tender size is below 5% of company value avoids triggering the general rule. The related-person rule may still apply to individual participants who tender more than their 2% de minimis, but the broader disqualification of all QSBS in the 2-year window is avoided.

For a $250M company, the 5% threshold is $12.5M of aggregate tender. Tender offers materially above this size cannot rely on the 5% safe harbor.

4. Limit individual tender participation to the de minimis threshold

The 2% de minimis safe harbor caps each individual's tender participation at 2% of their stock value (or $10K, whichever is greater). For a founder with $25M of stock, the 2% threshold is $500K — meaningful but limited liquidity.

Structuring the tender to limit individual participation to the de minimis amount preserves QSBS but provides modest liquidity. For founders willing to accept the trade-off (preserving multi-million-dollar tax savings in exchange for capped tender participation), the de minimis safe harbor is the conservative approach.

5. Section 1045 rollover instead of tender

For founders who want significant liquidity without the QSBS disqualification, an alternative is to sell QSBS outright and execute a section 1045 rollover into a new qualifying issuer. The original QSBS gain is deferred (not excluded yet), the holding period tacks into the replacement stock, and the section 1202 exclusion is preserved at the replacement issuer.

The downside: the proceeds are reinvested in early-stage QSBS, not received as liquid cash. Section 1045 is a deferral strategy, not a liquidity strategy. For founders genuinely needing cash, section 1045 does not solve the problem.

How the IRS analyzes tender redemptions

The IRS's analysis of tender offers under section 1202(c)(3) focuses on substance over form. The factual questions:

• Who is the actual buyer? If the buyer is the corporation, section 1202(c)(3) applies. If the buyer is a third party, the analysis turns on whether the third party is genuinely independent.
• Did the corporation arrange or finance the purchase? Corporate facilitation (introducing the buyer, providing diligence support, arranging financing) increases the risk of constructive-redemption characterization.
• Was the purchase price determined at arm's length? Below-market pricing or pricing tied to corporate guidance suggests substance-based redemption characterization.
• Are the buyer and the corporation related parties? A buyer that is a related party of the corporation under IRC section 267(b) is treated as the corporation for redemption purposes.
• What is the purpose of the transaction? While substance-based analysis does not turn on stated purpose, transactions structured primarily to circumvent section 1202(c)(3) (with the third party serving as a conduit for what is functionally a corporate redemption) may be recharacterized.

The defensive posture for founders: ensure the tender is conducted by a genuinely independent third party, with the corporation playing no role beyond providing standard diligence materials. Documentation of the third party's independence (origination, financing, valuation, due diligence) supports the third-party characterization.

Cleaning up after a tender: limiting damage

If a tender offer has disqualified some of a founder's QSBS, the damage is generally permanent. Several mitigation strategies can limit further damage:

• Identify which tranches are affected. Section 1202(c)(3) disqualification is tranche-specific. Tranches issued outside the 2-year windows retain their QSBS character. Detailed tracking of which tranches remain qualified is essential for the eventual sale.
• Plan exits to maximize qualified-tranche capture. For founders with both qualified and disqualified QSBS, structuring eventual sales to first dispose of the disqualified stock (which has no section 1202 benefit) and hold the qualified stock for the section 1202 exclusion at later sale can optimize the tax outcome.
• Per-taxpayer stacking still applies to qualified tranches. Even after disqualification of some tranches, the founder can gift remaining qualified QSBS to spouses and non-grantor trusts to multiply the per-taxpayer cap on the qualified portion.
• Future QSBS issuances after the 2-year-after window has closed. Stock issued more than 2 years after the disqualifying tender (assuming all other section 1202 requirements are met) is not affected by the prior tender. Future grants and exercises can build new qualified QSBS positions.

When the strategy is the wrong call

For some founders, the tender liquidity is more valuable than the QSBS protection:

• Cash flow needs. A founder with significant personal cash flow needs (medical, family, debt service, divorce) may legitimately need the tender liquidity regardless of QSBS impact. The 23.8% "cost" of QSBS disqualification on the eventual exit is real but secondary to current cash availability.
• Uncertain exit prospects. If the eventual exit is uncertain or low-probability, the QSBS preservation has lower expected value. A founder uncertain that the company will reach a successful exit may prefer the certain tender liquidity over the speculative QSBS exclusion.
• Diversification. Concentration risk in a single company's equity is itself a financial risk. A founder with $25M concentrated in one private company has legitimate diversification reasons to take liquidity even at the cost of QSBS treatment.
• Founder departure. If the founder is leaving the company and the QSBS character carries holding-period and active-business requirements that may become difficult to maintain post-departure, the tender liquidity may be the right call.

Recent trends in tender structuring

As the section 1202(c)(3) rules have become more widely understood, tender offer structures have evolved:

• Pure third-party tenders conducted by genuinely independent growth equity investors are the cleanest structure for QSBS preservation. These transactions look and operate like secondary market purchases.
• Capped tenders that limit aggregate participation below 5% of company value avoid the general rule but may still trigger the related-person rule for high-participation individuals.
• Founder-only tenders targeting only the founders (not employees) can be structured to clear safe harbors for the broader employee QSBS pool but may still disqualify the founders' own QSBS.
• Employee-only tenders structured to provide liquidity to non-founder employees, with founders abstaining, preserve the founder QSBS while addressing the employee retention concerns that motivate tenders.
• Section 1045 rollover combined with tender where founders use the tender proceeds to roll into other qualifying QSBS issuers — preserving section 1202 treatment through the rollover mechanism rather than the original company's QSBS.

Key takeaways

• IRC section 1202(c)(3) disqualifies stock from QSBS treatment when the corporation engages in significant redemptions during specified windows around the QSBS issuance. The rules apply to legitimate tender offers as well as abusive transactions.
• Two independent rules apply: the related-person rule (section 1202(c)(3)(A)) covering redemptions from the taxpayer or related persons within 2 years before or after issuance, and the general rule (section 1202(c)(3)(B)) covering aggregate redemptions exceeding 5% of company value within the 2-year window straddling issuance.
• Safe harbors: (1) the 2% de minimis rule for the related-person test (Treas. Reg. section 1.1202-2(a)(2)), and (2) the 5% threshold for the general rule. Both must be cleared independently to preserve QSBS.
• Genuine third-party tender purchases (where the buyer is independent of the corporation) generally do not trigger section 1202(c)(3) because the corporation is not the redeemer. Corporate-facilitated tenders may be recharacterized as constructive redemptions.
• Tender offer disqualification is tranche-specific. QSBS issued outside the 2-year windows retains qualification. Tracking which tranches are affected is essential for the eventual sale.
• Section 1045 rollover is an alternative for founders wanting liquidity without QSBS disqualification — but requires reinvestment in replacement QSBS rather than receipt of liquid cash.
• The economic cost of QSBS disqualification at exit is approximately 23.8% of the disqualified gain. For a $20M disqualification, the cost is roughly $4.76M of federal tax that would have been avoided under QSBS treatment.
• Tender structuring decisions must be made BEFORE the tender closes. Retroactive fixes are not available. Tax counsel should confirm the section 1202(c)(3) analysis in writing before any tender offer is executed.